Immune checkpoint proteins (PD-L1 and CTLA-4) in endometrial carcinoma: prognostic role and correlation with CD4 ⁺ /CD8 ⁺ tumor infiltrating lymphocytes (TILs) ratio.

Autor: Khalifa R; Department of pathology, Faculty of Medicine, Pathology, Tanta University, Tanta, Egypt., Elsese N; Department of pathology, Faculty of Medicine, Pathology, Tanta University, Tanta, Egypt., El-Desouky K; Department of pathology, Faculty of Medicine, Pathology, Tanta University, Tanta, Egypt., Shaair H; Department of pathology, Faculty of Medicine, Pathology, Tanta University, Tanta, Egypt., Helal D; Department of pathology, Faculty of Medicine, Pathology, Tanta University, Tanta, Egypt.

Publikováno v: Journal of immunoassay & immunochemistry [J Immunoassay Immunochem] 2022 Mar 04; Vol. 43 (2), pp. 192-212. Date of Electronic Publication: 2021 Oct 26.

Network-based drug repurposing identifies small molecule drugs as immune checkpoint inhibitors for endometrial cancer.

Autor: Ahmed F; Department of Mechatronics Engineering, Jeju National University, Jeju, Republic of Korea., Samantasinghar A; Department of Mechatronics Engineering, Jeju National University, Jeju, Republic of Korea., Ali W; Department of Mechatronics Engineering, Jeju National University, Jeju, Republic of Korea., Choi KH; Department of Mechatronics Engineering, Jeju National University, Jeju, Republic of Korea. amm@jejunu.ac.kr.

Publikováno v: Molecular diversity [Mol Divers] 2024 Jan 16. Date of Electronic Publication: 2024 Jan 16.